MOUNTAIN VIEW, Calif., Sept. 15, 2011 /PRNewswire/ — Alexza
Pharmaceuticals, Inc. (Nasdaq:
ALXA) announced today that the company will participate in the
Sixth Annual JMP Securities Healthcare Conference, being held in
New York, New York, September 27 – 28, 2011. The Alexza
corporate presentation will be Wednesday, September 28, 2011 at
10:30 am ET. The presentation will be webcast live.
To access the presentation via the Web, please go to the
Investor Relations tab at www.alexza.com or directly at http://wsw.com/webcast/jmp14/alxa/.
A replay of the webcast will be available approximately 24
hours after the live presentation and archived for 14 days.
About Alexza Pharmaceuticals, Inc.
Alexza is a pharmaceutical company focused on the research,
development and commercialization of novel, proprietary products
for the acute treatment of central nervous system conditions.
Alexza’s technology, the Staccato® system, vaporizes
unformulated drug to form a condensation aerosol that, when
inhaled, allows for rapid systemic drug delivery through deep lung
inhalation. The drug is quickly absorbed through the lungs
into the bloodstream, providing speed of therapeutic onset that is
comparable to intravenous administration, but with greater ease,
patient comfort and convenience. (Click
here to see an animation of how the Staccato system
works.)
Adasuve™ (Staccato loxapine), Alexza’s lead
program, is being developed for the rapid treatment of agitation in
adults with schizophrenia or bipolar disorder. Alexza has
completed and announced positive results from both of its Phase 3
clinical trials and initially submitted the ADASUVE NDA in
Dece
‘/>”/>
SOURCE
